2:15PM – 3:o0PM, January 26, 2015 – Impact of Genomics on Cancer Care @Silicon Valley 2015 Personalized Medicine World Conference, Mountain View, CA
Reporter: Aviva Lev-Ari, PhD, RN
Real Time Conference Coverage with Social Media
@Computer History Museum by Dr. Aviva Lev-Ari, PhD, RN
Session Chair: Frank S. Ong, Illumina (Chair)
2:15PM – 2:30PM Kim Popovits, Genomic Health
Transforming the Cancer Patient Journey with Actionable Genomic Information
LIVE from the Podium
- Proprietary technology for DIagnosis – new workflow
- Genome profile – no need to wait 3 months to next CT to see shrinkage of Tumor
- Mutation Pane for patients that drug did not shrinking the tumor
- multiple genes, higher Tumor burden
- leveraging Genomic Health’s Leading Brand and Channel to Capture
2:30PM – 2:45PM Janusz Dutkowski, Data4Cure
LIVE from the PODIUM
- Two goals vs many predictions
- Universe of Data: Predictions still dat poor, linear,
- biological complexity
- Cancer genome interpretation
- Genome analysis – data boosted
- Actionable Drivers: algorithms
- common and rare variants
- Molecular hierarchy: Pathways, genes, complex, processes
- Multiscale cancer maps – Context matter
- GBM Biomarkers – Brain Tumors
- Human knowledge is critical: Scientists and Clinicians
- Learn, collaborate, apply, share, collaborate, laern share — biological knowledge iteration
Personal Systems Interpretation: a Multidimensional View Into Cancer
2:45PM – 3:00PM Martin Naley, Cure Forward
The Coming Genomics Boom: Will Patients Be The Catalyst?
LIVE FROM THE PODIUM
- Will the patient be the Catalyst? Genomics Boom gained Presidents support
- Introduction to services
- development of personal genome sequencing 23andMe
- Precision medicine – Dana Farber — EVERY PATIENT ENTERING WITH CANCER DIAGNOSIS, RECEIVE A GENOME SEQUENCES
- Oncology trial statistics – 85% participate, 88% reports experience is positive
- Clinical Trials have difficulty filling up the Trials
Eric Topol, The Patient will see you NOW!!
- shred the snare
Trial comes to the Patient
- CureForward: Donate data, match, assist patients
- diagnostics test providers
Comments from the Audience
interpretation of the biology remains a major challenge in the field, the advances represent technology, sequencing efficacy, mapping with reduced error –that development is not coupled with a parallel advancing of the ability to translate the Genomics research into the discipline of Biology beyond concordance, affinity and statistical correlations. The Biology Departments need to be brought closer to the Genomics Centers.
Leave a Reply